Amyloid Cardiomyopathy, Transthyretin-Related research hub

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

This study looks at the long-term safety of a drug called acoramidis (AG10) for people with a serious heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM). It's for those who already finished an earlier study.